09:35 EDT Xilio Therapeutics (XLO) files $250M mixed securities shelf
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on XLO:
- Xilio Therapeutics reports Q4 EPS (20c) vs (64c) last year
- Biotech Alert: Searches spiking for these stocks today
- Xilio Therapeutics: Innovative TCE Platform and Strategic AbbVie Partnership Justify Buy Rating
- Xilio (XLO) Stock Zooms 125% Higher On Cancer Fighting Deal with AbbVie
- Xilio Therapeutics Partners with AbbVie for Immunotherapy Expansion